$0.82 0.02 (+2.17%)
2/13/2012 11:45 AM

DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Featured Broker Partners


Advertisement